New Data Strengthens Teva’s Schizophrenia Portfolio, Including Phase 3 SOLARIS Trial Survey Results Demonstrating Patient and Healthcare Professional Satisfaction with TEV-'749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable 1-04-2025, 00:00

Wurl Launches ContentDiscovery to Help Streamers and Content Publishers Attract, Engage, and Retain Viewers at Massive Scale 15-05-2023, 20:03

Nitro Rallycross Reveals First Image of Calgary Track, 1-02-2023, 02:46